FrontierLab
A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

STAAR Surgical Company STAA

Strong   broader-coverage candidate · STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implant

On FrontierLab's discovery record since 2026-07-09 (6 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Strong" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-08-18), not the curated Frontier signal.

Key quality signals

Revenue growth (YoY)51.3%
Gross margin76.2%
Gross profits / assets0.54
Rule of 4061.6
Net margin10.3%
Cash runway (months)120
PEG
Price / sales3.5

Quality checklist

Fundamentals — snapshot as of 2026-08-18

StageEstablished
Share issuance (YoY)4% · modest issuance
Moat
TAM
P/E (trailing)301.1
EPS (trailing)$0.08
Burn multiple
Gross-margin trend (pts)4.5
Cash / assets0.38
Net debt / EBITDA-3.5
Statements as ofQ2 FY2026 · filed 2026-08-12

Momentum context — a snapshot from 2026-08-18, not current

Price at surface$24.09 (as of 2026-08-18)
52-week range$15.59 – $35.87
% off 52-wk high-32.8%
RSI (14)44
Relative volume1.4×

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-08-18 (end-of-day). How grades are computed →